Details for New Drug Application (NDA): 018901
✉ Email this page to a colleague
NDA 018901 describes AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE profile page.
The generic ingredient in AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
The generic ingredient in AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
Summary for 018901
| Tradename: | AMINESS 5.2% ESSENTIAL AMINO ACIDS W/ HISTADINE |
| Applicant: | Hospira |
| Ingredient: | amino acids |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5.2% (5.2GM/100ML) | ||||
| Approval Date: | Apr 6, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
